SCYNEXIS, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
SCYNEXIS, Inc. (SCYX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $759.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-04
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $759.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $744.00K.
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $744.00K.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $744.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $759.00K 10-K · filed 2026-03-04 |
| 2024-12-31 | $744.00K 10-K · filed 2025-03-12 |
| 2024-09-30 | $744.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $744.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $744.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $730.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $730.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $730.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $730.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $715.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $715.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $715.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $715.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $527.00K 10-K · filed 2022-03-29 |
| 2021-09-30 | $527.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $527.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $527.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $517.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $517.00K 10-Q · filed 2020-11-06 |
| 2019-12-31 | $507.00K 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |